Cargando…
The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
Smad7 was initially identified as an inhibitor of Transforming growth factor (TGF)-β due mainly to its ability to bind TGF-β receptor type I and prevent TGF-β-associated Smad signaling. More recently, it has been demonstrated that Smad7 can interact with other intracellular proteins and regulate als...
Autores principales: | Stolfi, Carmine, Marafini, Irene, De Simone, Veronica, Pallone, Francesco, Monteleone, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876077/ https://www.ncbi.nlm.nih.gov/pubmed/24317436 http://dx.doi.org/10.3390/ijms141223774 |
Ejemplares similares
-
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
por: Stolfi, Carmine, et al.
Publicado: (2020) -
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
por: Troncone, Edoardo, et al.
Publicado: (2018) -
Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
por: Troncone, Edoardo, et al.
Publicado: (2021) -
The Dual Role of Inflammation in Colon Carcinogenesis
por: Monteleone, Giovanni, et al.
Publicado: (2012) -
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
por: Monteleone, Giovanni, et al.
Publicado: (2022)